SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is drawing heavy retail attention after positive Phase 2 weight-loss maintenance and tolerability data for VK2735, with sentiment on the platform shifting to extremely bullish on elevated message volume. Bulls argue the results de-risk the drug ahead of Phase 3, fueling short-squeeze talk and renewed takeover speculation, while skeptics point to the muted stock reaction, sell-the-news profit taking, and dilution concerns tied to the company's $500 million shelf offering.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio (IBRX) is trending after founder Patrick Soon-Shiong teased a potential push into blockchain-based tokenized stock trading at Nant, with traders speculating that tokenizing IBRX shares could curb naked short selling and squeeze elevated short interest. Skeptics caution the tease is not an official company announcement, while unconfirmed community speculation about Soon-Shiong's meeting with Turkey's president and a possible Anktiva expansion there adds to the chatter.

Uber Technologies, Inc. is a technology platform, which engages in the development and operation of technology applications, networks, and product to power movement from point A to point B. The firm offers ride services and merchants delivery service providers for meal preparation, grocery, and other delivery services. It operates through the following segments: Mobility, Delivery, and Freight. The Mobility segment refers to products that connect consumers with mobility drivers who provide rides in a variety of vehicles, such as cars, auto rickshaws, motorbikes, minibuses, and taxis. The Delivery segment offers consumers the chance to search for and discover local restaurants, order a meal, and either pick-up at the restaurant or have the meal delivered. The Freight segment focuses on connecting carriers with shippers on its platform, and gives carriers upfront, transparent pricing, and the ability to book a shipment. The company was founded by Oscar Salazar Gaitan, Travis Kalanick, and Garrett Camp in 2009 and is headquartered in San Francisco, CA.

Uber Technologies Inc

UBER is trending as traders question why the stock keeps selling off at the open and staying red despite a stream of positive developments, most prominently CEO Dara Khosrowshahi's $10 million open-market share purchase and a roughly $5.3 million buy by the COO. The community is split between reading the insider buying, along with Bill Ackman's disclosed bullish stake, as accumulation at a bottom, and attributing the weakness to autonomous-vehicle competition fears around Tesla and Waymo robotaxis, suspected short-selling pressure or manipulation, and some citing uncertainty over the Delivery Hero acquisition financing.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending as retail traders react to CEO Ryan Cohen adding roughly $26.4 million in open-market sharesa follow-on purchase viewed by many as a signal of insider convictionamid a sustained runup in the stock and active discussion of warrants and a potential short squeeze. The community is split: some traders expect squeeze or buyback catalysts, while skeptics attribute the rally to bond-holder activity, declining short interest, or alleged market manipulation rather than Cohen's buying.

Innodata, Inc. is a data engineering company, which engages in providing artificial intelligence software platforms and management of its services. It operates through the following business segments: Digital Data Solutions (DDS), Synodex, and Agility. The DDS segment combines deep neural networks and human expertise in multiple domains to make unstructured information useable. The Synodex segment enables clients in the insurance and healthcare sectors to transform medical records into useable digital data and to apply technologies to the digital data to augment decision support. The Agility segment provides tools and related professional services that enable public relations and communications professionals to discover influencers, amplify messages, monitor coverage, and measure the impact of campaigns. The company was founded by Todd H. Solomon in 1988 and is headquartered in Ridgefield Park, NJ.

Innodata Inc

Innodata is drawing attention around its AI evaluation and red-teaming push, with traders pointing to the Innodata Muse announcement and the addition of former NSA Director Admiral Michael Rogers to the board as an AI-security signal. The community is split on what drove the rally, with some crediting the news and a broader AI-safety theme while others argue the move is a technical breakout amplified by a short squeeze rather than news-driven.

Royal Caribbean Group is a cruise company, which engages in the ownership and operation of the following global cruise brands: Royal Caribbean International, Celebrity Cruises, and Silversea Cruises. The firm also holds interest in TUI Cruises GmbH, which operates the German brands TUI Cruises and Hapag-Lloyd Cruises. The company was founded by Arne Wilhelmsen in 1968 and is headquartered in Miami, FL.

Royal Caribbean Group

Discussion is fragmented rather than centered on a single catalyst, with the most common themes being oil price volatilityfuel costs, Royal Caribbean's fuel hedging versus unhedged peers CCL and NCLH, and Iran/Strait of Hormuz headlinesand a sharp debate over short-selling, which traders variously call manipulation or an easy short. Smaller threads criticize the company's resort acquisition, cite travel fears from a hantavirus outbreak on a cruise ship, and react to a beat-and-raise earnings report.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. The firm operates through the following geographical segments: United States and International. It offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

The Trade Desk is trending amid a steep, sustained share decline following its removal from the S&P 500, with traders split on whether index-related selling drove the drop or was largely priced in as growth slows. Heavy short interest is fueling speculation of a potential short-covering rally, while criticism of managementover executive share sales, option repricing, and competition from Amazon, Google, and Metadrives much of the bearish commentary.

Omeros Corp. operates as a biopharmaceutical company, which engages in the research, discovery, development, and commercialization of small-molecule and protein therapeutics targeting immunologic diseases. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros is drawing heavy attention after a sharp rally to multi-year highs on a large quarterly revenue beat (roughly $32M versus ~$12M expected), which traders credit to the early commercial ramp of Yartemlea (narsoplimab) against a still-small ~$1.5B market cap. The heavily bullish discussion centers on whether elevated short interest could fuel a squeeze if shares break $20, with competing debate over EU re-examination hopes, possible buyout interest, and caution from some that the crowd may be getting ahead of the fundamentals.

Trulieve Cannabis Corp. engages in the cultivation, processing, manufacturing, and retail distribution of medical and adult-use cannabis products. It cultivates and produces its products in-house and distributes to its branded stores, as well as directly to patients via home delivery. The company was founded by Kim Rivers & Jason Pernell on September 17, 1940 and is headquartered in Tallahassee, FL.

Trulieve Cannabis Corp - Ordinary Shares (Sub Voting)

Trulieve Cannabis Corp 

Trulieve is trending as traders speculate that a DEA decision to reschedule marijuana to Schedule III is imminent, with rumors circulating that an announcement could come after market close and hopes of a short squeeze if federal cannabis reform news hits. The buzz follows the company's NYSE uplisting and Q2 results, and the community is split between bulls anticipating a reform-driven rally and skeptics pointing to weakening technicals, bearish sentiment, and claims that shorts are hunting stop losses.

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services. The company was founded in April 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SoFi is trending on its launch of SoFiUSD, becoming the first national bank to run stablecoin settlement across Mastercard's global payments network as it migrates its roughly $25 billion card program to blockchain-based settlement. Premarket gains faded at the open, fueling a sharp debate between bulls touting the long-term payments innovation and bears calling it a sell-the-news event, with many traders alleging heavy shorting or manipulation of the stock.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$SLNO Outstanding article that hits the mark on SLNO&#39;s current state. So if you want to refresh your SLNO insights or learn about SLNO from scratch, this is a must read. https://everyticker.com/quote/SLNO/analysis/soleno-s-2-9b-validation-why-neurocrine-is-paying-53-for-a-drug-that-didn-t-exist-18-months-ago-nasdaq-slno

The Neurocrine Biosciences (TICKER:NBIX) acquisition at $53 per share represents a validation of Soleno's transformation from a development-stage biotech to a profitable rare disease leader, crystalli...

EveryTicker

Soleno's $2.9B Validation: Why Neurocrine Is Paying $53 for a Drug That Didn't Exist 18 Months Ago (NASDAQ:SLNO) - SLNO Research Report

StockTwits Web

Soleno Therapeutics Inc

 Outstanding article that hits the mark on SLNO's current state. So if you want to refresh your SLNO insights or learn about SLNO from scratch, this is a must read. 